According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.
Growth
in this market is primarily driven by the rising incidence of
infectious diseases; technological advancements towards the development
of rapid AST technologies; increased funding, research grants, and
public-private investments; growing government initiatives to detect and
control antimicrobial-resistant species; and the emergence of multidrug
resistance due to drug abuse.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984
Based on the product,
the antimicrobial susceptibility testing market is segmented into
automated laboratory instruments, manual antimicrobial susceptibility
testing products, culture and growth media, and consumables. The manual
susceptibility testing products segment is further divided into
susceptibility testing disks, MIC strips, and susceptibility testing
plates. Among the manual antimicrobial susceptibility testing products,
the susceptibility testing disks segment held a major share of the
market in 2019. The high quality, low cost, and ease of use of these
products are increasing the adoption of susceptibility testing disks in
emerging countries. Some prominent players offering susceptibility
testing disks include BD (US), Thermo Fisher Scientific, Inc. (US),
Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
Based on application,
the antimicrobial susceptibility testing market has been segmented into
the market is segmented into clinical diagnostics, drug discovery and
development, epidemiology, and other applications. Significant market
growth in the clinical diagnostics segment can be attributed to the
rising burden of infectious diseases, the growing burden of
antimicrobial resistance, and new product launches in the market.
Based on type,
the market has been segmented into the antibacterial susceptibility
testing, antifungal susceptibility testing, antiparasitic susceptibility
testing, and susceptibility testing types. Among these, the
antibacterial susceptibility testing segment dominated the market in
2019. The major share of the segment is attributed to the presence of
regulatory guidelines to streamline the process of antibacterial
susceptibility testing, technological advancements, and the rising
burden of antibacterial resistance in developing as well as developed
countries.
The competitive landscape includes the analysis of the
key growth strategies adopted by major players between 2017–2020 to
expand their global presence and increase their market shares in the
antimicrobial susceptibility testing market. The key growth strategies
adopted by the top players in the market include product launches and
approvals, agreements, expansions, and acquisitions. Product approvals
and launches were the most widely adopted growth strategies by market
players in the last three years to garner a larger share of the market.
In 2019, the antimicrobial susceptibility testing market was dominated
by bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo
Fisher Scientific (US), Danaher Corporation (US), and Bio-Rad
Laboratories, Inc. (US).
bioMérieux SA (France)
is a leader in the global AST market. bioMérieux is a developer of
innovative solutions for clinical diagnostics and industrial
microbiological control in fields such as the agri-food sector,
environmental monitoring, and veterinary diagnostics. The comprehensive
range of products, high focus on R&D (to deliver novel products in
the market), and strong geographical presence are the key factors
contributing to the major market share of the company in the AST market.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984
North
America, comprising the US and Canada, accounted for the largest share
of the antimicrobial susceptibility testing market in 2019.
Technological advancements in rapid antimicrobial susceptibility testing
systems, rising incidence of infectious diseases (such as AIDS,
tuberculosis, and pertussis), and government support for antimicrobial
resistance-related research are the major factors driving market growth
in North America. As AST through conventional methods is a lengthy
process, customers in North America are moving towards rapid AST
techniques, which require minimal reagents. This trend will have a
positive impact on the automated instruments market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com